NSAIDs and prostate cancer risk

Cancer Journal

Volumn 12, Issue 2, 2006, Pages 108-109

  DuBois, Raymond N ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG FATALITY; DRUG SAFETY; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATITIS; SOLID TUMOR; THROMBOSIS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATROPHY; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION; MALE; PROSTATE; PROSTATIC NEOPLASMS; UP-REGULATION;

EID: 33645862538     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Dasgupta K, Di Cesar D, Ghosn J et al. Association between the non-steroidal anti-inflammatory drugs and the occurrence of prostate cancer. Cancer J 2006;12:130-135.
2. Habel LA, Zhao W, Stanford JL. Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control 2002;13:427-434.
3. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
4. Gupta RA, DuBois RN. Colorectal cancer and the cyclooxygenase pathway. Nat Rev Cancer 2001;1:11-21.
5. Zha S, Gage WR, Sauvageot J et al. Cyclooxygenase-2 is upregulated in proliferative inflammatory atrophy of the prostate but not in prostate carcinoma. Cancer Res 2001;61:8617-8623.
6. Palayoor ST, Arayankalayil MJ, Shoaibi A, Coleman CN. Radiation sensitivity of human carcinoma cells transfected with small interfering RNA targeted against cyclooxygenase-2. Clin Cancer Res 2005;11:6980-6986.
7. Wang W, Bergh A, Damber JE. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res 2005;11:3250-3256.
8. Patel MI, Subbaramaiah K, Du B et al. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res 2005;11:1999-2007.
9. Hughes-Fulford M, Li CF, Boonyaratanakornkit J, Sayyah S. Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Res 2006;66:1427-1433.
10. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006;116:4-15.